Prescription drug · ANDA
Benzonatate NDC 67296-2202
Benzonatate 200 mg/1 · Capsule, Liquid filled · Oral · Redpharm Drug
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67296-2202-3 | 67296220203 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (67296-2202-3)Marketed from Sep 29, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Benzonatate
- Generic name (nonproprietary)
- benzonatate
- Active ingredients
- Benzonatate — 200 mg/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Labeler
- Redpharm Drug
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040682
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Tracheobronchial Stretch Receptor Activity (Physiologic effect)
- Identifiers
- Product ID 67296-2202_46e97552-8f98-7fd1-e063-6394a90a3c92SPL ID 46e97552-8f98-7fd1-e063-6394a90a3c92SPL set ID 46e97547-23d9-114a-e063-6394a90a920bRxCUI 283417UNII 5P4DHS6ENR
- Pharmacologic class
- Non-narcotic Antitussive
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467296220203followed by a unit qualifier and the quantityPackage 67296-2202-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Benzonatate is indicated for the symptomatic relief of cough.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040682
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-441 |
| Benzonatate | Benzonatate 100 mg/1 | CapsuleOral | Chartwell RX, LLC | 62135-440 |
| Benzonatate | Benzonatate 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2021 |
| Benzonatate | Benzonatate 100 mg/1 | Capsule, Liquid filledOral | Amneal Pharmaceuticals LLC | 65162-536 |
| Benzonatate | Benzonatate 200 mg/1 | Capsule, Liquid filledOral | Amneal Pharmaceuticals LLC | 65162-537 |
| Benzonatate | Benzonatate 200 mg/1 | Capsule, Liquid filledOral | Bryant Ranch Prepack | 71335-3169 |
| Benzonatate | Benzonatate 100 mg/1 | Capsule, Liquid filledOral | Redpharm Drug | 67296-2207 |
| Benzonatate | Benzonatate 100 mg/1 | Capsule, Liquid filledOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-898 |
| Benzonatate | Benzonatate 200 mg/1 | Capsule, Liquid filledOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-899 |
| Benzonatate | Benzonatate 100 mg/1 | Capsule, Liquid filledOral | Proficient Rx LP | 63187-076 |